Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition) PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK

TEST BANK PHARMACOLOGY
n n n




9TH EDITION, 2017) MCCUISTI
n n n




ON

,TEST BANK PHARMACOLOGY
n n




(A Patient-
n




Centered Nursing ProcessApproach 9
n n n n




TH EDITION, 2017) MCCUISTION
n n n

, Table of Contents
n n

Chaptern28:nPeptides,nAntimalarial,nand
Chaptern01:nDrugnDevelopmentnandn Anthelmintic
EthicalnConsiderations Chaptern29:nHIV-nandnAIDS-
Chaptern02:nPharmacokinetics,n RelatednDrugs
Pharmacodynamics,nandnPhar Chaptern30:nTransplantnDrugsn
macogenetics Chaptern31:n VaccinesnChapte
Chaptern03:nCulturalnConsiderationsn rn32:nAnticancernDrugs
Chaptern04:nComplementarynandnAlt Chaptern33:nTargetednTherapiesntonTreatn
ernativenTherapies Cancer
Chaptern05:nPediatricnConsiderationsn Chaptern34:nBiologicnResponsen
Chaptern06:nGeriatricnConsiderationsn Modifiers
Chaptern07:nDrugsninnSubstancenUsen Chaptern35:nUppernRespiratoryn
Disorder Disorders
Chaptern08:nThenNursingnProcessnandn Chaptern36:nLowernRespiratoryn
Patient-CenterednCare Disorders
Chaptern09:nSafetynandnQualityn Chaptern37:nCardiacnGlycosides,nA
Chaptern10:nDrugnAdministrationn ntianginals,nandnAntidysrhythmicsnC
Chaptern11:nDrugnCalculationsnC haptern38:nDiuretics
haptern12:nFluidnVolumenandnEle Chaptern39:nAntihypertensive
ctrolytes Chaptern40:nAnticoagulants,nAntiplat
Chaptern13:nVitaminnandnMineraln elets,nandnThrombolyticsnChaptern41
Replacement :nAntihyperlipidemicsnandnPeripheraln
Chaptern14:nNutritionalnSupportnChap Vasodilators
tern15:nAdrenergicnAgonistsnandnAntag Chaptern42:nGastrointestinalnTractn
onists Disorders
Chaptern16:nCholinergicnAgonistsnandn Chaptern43:nAntiulcernDrugsnChapte
Antagonists rn44:nEyenandnEarnDisordersnChapter
Chaptern17:nStimulants n45:nDermatologicnDisordersn Chapter
Chaptern18:nDepressantsnCha n46:nPituitary,nThyroid,nParathyroid,n

ptern19:nAntiseizurenDrugs andnAdrenalnDisordersnChaptern47:n
Chaptern20:nDrugsnfornParkinsonismnandn Antidiabetics
Alzheimer'snDisease Chaptern48:nUrinarynDisordersnChapt
Chaptern21:nDrugsnfornNeuromuscularn ern49:nPregnancynandnPretermnLabor
DisordersnandnMusclenSpasmsnChapt Chaptern50:nLabor,nDelivery,nandn
ern22:nAntipsychoticsnandnAnxiolytics Postpartum
Chaptern23:nAntidepressantsnandnMoodn Chaptern51:nNeonatalnandnNewbornn
Stabilizers Chaptern52:nWomen'snReproductiven
Chaptern24:nAntiinflammatories Health
Chaptern25:nAnalgesics Chaptern53:nMen'snReproductivenHealthn
Chaptern26:nAntibacterials Chaptern54:nSexuallynTransmittednInfect
Chaptern27:nAntituberculars,nAntifungals,n ions
andnAntivirals Chaptern55:nAdultnandnPediatricn
EmergencynDrugs

TestnBankn-nPharmacology:nAnPatient-CenterednNursingnProcessnApproachn(9thnEdition,n2017)
PHARMACOLOGYn9THnEDITIONnMCCUISTIONnTESTnBANK
https://shopping-4-less.weebly.com/

, TestnBankn-nPharmacology:nAnPatient-CenterednNursingnProcessnApproachn(9thnEdition,n2017)
PHARMACOLOGYn9THnEDITIONnMCCUISTIONnTESTnBANK
https://shopping-4-less.weebly.com/



Chapter 01: Drug Development and Ethical Considerations
n n n n n n

MULTIPLEnCHOICE
1. ThennursenisnpreparingntonadministernanschedulenIIninjectablendrugnandnisndrawingnupnhalfnofnt
hencontentsnofnanSingle-usenvial.nWhichnnursingnactionnisncorrect?
a. Asknanothernnursentonobservenandncosignnwastingnthenremainingndrugnfromnthenvial.
b. Keepnthenremainingnamountninnthenpatient’sndrawerntongivenatnthennextndose.
c. Recordnthenamountnunusedninnthenpatient’snmedicationnrecord.
d. Disposenofnthenvialnwithnthenremainingndrugnintonanlockedncollectionnbox.n
ANS:nA
SchedulenIIndrugsnarencontrollednsubstances,nandnallnmustnbenaccountednfor.nWhennwastingnanportio
nnofnandrug,nanothernnursenshouldnobservenandncosignnthatnandrugnwasnwasted.
DIF:nCOGNITIVEnLEVEL:nApplyingn(Application)n
TOP:nNURSINGnPROCESS:nNursingnIntervention
MSC:nNCLEX:nPhysiologicalnIntegrity:nPharmacologicalnandnParenteralnTherapies

2. Anpatientnisnprescribednanmedicationnandnasksnthennursenifnthendrugnisnavailableninnangenericnf
orm.nThennursenunderstandsnthatnangenericnmedicationnwillnhavenannamenthat
a. isnanregisteredntrademark.
b. isnalwaysncapitalized.
c. describesnthendrugsnchemicalnstructure.
d. isnnon-
proprietary.nANS:nD
Thengenericnnamenisnthenofficial,nnon-
proprietarynnamenfornandrug.nThenbrandnnamenisnthentrademarknnamenandnisnalwaysncapitalized.nT
henchemicalnnamendescribesnthenchemicalnstructurenofnthendrug.
DIF:nCOGNITIVEnLEVEL:nUnderstandingn(Comprehension)nT
OP:nNURSINGnPROCESS:nN/A
MSC:nNCLEX:nPhysiologicalnIntegrity:nPharmacologicalnandnParenteralnTherapies

3. Anpatientnreceivesnanprescriptionnonnwhichnthenprovidernhasnnotednthatnangenericnmedicationn
maynbengiven.Thenpatientnasksnthennursenwhatnthisnmeans.nWhatnwillnthennursentellnthenpatientna
boutngenericndrugs?
a. Theyncontainnthensameninertningredientsnasnbrand-namendrugs.
b. Theynhavenchemicalnstructuresnthatnarenidenticalntonproprietaryndrugs.
c. Theyntendntonbenlessnexpensiventhannbrand-namendrugs.
d. Theynundergonextensiventestingnbeforentheynarenmarketed.n
ANS:nC
GenericndrugsnarenapprovednbynthenFDAnifntheynarenprovedntonbenbioequivalentntonthenbrand-
nnamendrug.nTheyntendntonbenlessnexpensivenbecausenmanufacturersnof nthesendrugsndonnotnhaven t
ondonthenextensiventestingnrequirednofnbrand-
namendrugsnbeforenmarketing.nTheynarennotnidenticalntonbrand-
namendrugsnandnoftennhavendifferentninertningredients.
DIF:nCOGNITIVEnLEVEL:nApplyingn(Application)
TOP:nNURSINGnPROCESS:nNursingnIntervention:nPatientnTeachingnMSC
:nNCLEX:nManagementnofnClientnCare

4. ThennursenreviewsninformationnaboutnandrugnandnnotesntheninitialsnUSPnafternthendrugsnofficialnn
ame.nThennursenunderstandsnthatnthisndesignationnindicatesnthendrug
TestnBankn-nPharmacology:nAnPatient-CenterednNursingnProcessnApproachn(9thnEdition,n2017)
PHARMACOLOGYn9THnEDITIONnMCCUISTIONnTESTnBANK
https://shopping-4-less.weebly.com/